SHR-1139

· Guangdong Hengrui Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for SHR-1139, covering 2025-07-14 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of SHR-1139 in Healthy Volunteers [Phase 1]